Actionable news
All posts from Actionable news
Actionable news in AMGN: Amgen Inc.,

U.S. FDA knocks back Novartis copy of Amgen's drug Neulasta

July 19 (Reuters) - U.S. regulators have declined to approve Novartis' so-called biosimilar copy of Amgen's Neulasta drug that fights infections in cancer patients, the Swiss drugmaker said on Tuesday.

Vasant Narasimhan, head of...